Colorectal cancer: the first neoplasia found to be under immunosurveillance and the last one to respond to immunotherapy?
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Colorectal cancer: the first neoplasia found to be under immunosurveillance and the last one to respond to immunotherapy?
Authors
Keywords
-
Journal
OncoImmunology
Volume 4, Issue 7, Pages e1058597
Publisher
Informa UK Limited
Online
2015-06-06
DOI
10.1080/2162402x.2015.1058597
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
- (2015) Padmanee Sharma et al. CELL
- Classification of current anticancer immunotherapies
- (2015) Lorenzo Galluzzi et al. Oncotarget
- Heteroclitic XBP1 peptides evoke tumor-specific memory cytotoxic T lymphocytes against breast cancer, colon cancer, and pancreatic cancer cells
- (2015) Jooeun Bae et al. OncoImmunology
- Impact of myeloid cells on the efficacy of anticancer chemotherapy
- (2014) Laura Senovilla et al. CURRENT OPINION IN IMMUNOLOGY
- Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens
- (2014) Matthew M. Gubin et al. NATURE
- Microbiota organization is a distinct feature of proximal colorectal cancers
- (2014) Christine M. Dejea et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A novel combinatorial cancer immunotherapy
- (2014) Toshihiro Nagato et al. OncoImmunology
- Screening of novel immunogenic cell death inducers within the NCI Mechanistic Diversity Set
- (2014) Abdul Qader Sukkurwala et al. OncoImmunology
- The immune landscape of human tumors
- (2014) Gabriela Bindea et al. OncoImmunology
- Consensus guidelines for the detection of immunogenic cell death
- (2014) Oliver Kepp et al. OncoImmunology
- Trial Watch
- (2014) Erika Vacchelli et al. OncoImmunology
- Immunosurveillance against tetraploidization-induced colon tumorigenesis
- (2013) Alice Boilève et al. CELL CYCLE
- Mechanism of Action of Conventional and Targeted Anticancer Therapies: Reinstating Immunosurveillance
- (2013) Laurence Zitvogel et al. IMMUNITY
- Immunogenic Cell Death in Cancer Therapy
- (2012) Guido Kroemer et al. Annual Review of Immunology
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
- (2012) Julie R. Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- An Immunosurveillance Mechanism Controls Cancer Cell Ploidy
- (2012) L. Senovilla et al. SCIENCE
- Trial watch
- (2012) Laura Senovilla et al. OncoImmunology
- Prognostic and Predictive Impact of Intra- and Peritumoral Immune Infiltrates
- (2011) W. H. Fridman et al. CANCER RESEARCH
- Molecular mechanisms of cisplatin resistance
- (2011) L Galluzzi et al. ONCOGENE
- Phase II Study of the Anti-Cytotoxic T-Lymphocyte–Associated Antigen 4 Monoclonal Antibody, Tremelimumab, in Patients With Refractory Metastatic Colorectal Cancer
- (2010) Ki Y. Chung et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates
- (2010) Julie R. Brahmer et al. JOURNAL OF CLINICAL ONCOLOGY
- Immunogenic death of colon cancer cells treated with oxaliplatin
- (2009) A Tesniere et al. ONCOGENE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started